Table 6.
Japanese | Total | Males | Females | |||||
References | n | M ± SD | n | M ± SD | n | M ± SD | ||
Serum | ||||||||
Albumin | g/dL | 3.8–5.3 | 135 | 4.3 ± 0.4 | 72 | 4.3 ± 0.4 | 63 | 4.3 ± 0.3 |
ALT | IU/L | 5–35 | 135 | 27.2 ± 24.4 | 72 | 30.4 ± 28.1 | 63 | 24.4 ± 19.4 |
BUN | mg/dL | 8.0–23 | 135 | 14.3 ± 4.3 | 72 | 15.1 ± 4.3 | 63 | 13.5 ± 4.1 |
Fe | μg/dL | M50-200, F40-180 | 71 | 104.6 ± 39.4 | 39 | 119.8 ± 39.7 | 32 | 86.0 ± 30.3 |
Uric acid | mg/dL | M3.8-7.5, F2.4-5.8 | 135 | 4.8 ± 1.4 | 72 | 5.4 ± 1.4 | 63 | 4.1 ± 1.0 |
Folic acid | ng/mL | >3.1 | 71 | 4.1 ± 1.6 | 39 | 3.7 ± 1.3 | 32 | 4.6 ± 1.8 |
Vitamin A | IU/dL | 97–316 | 71 | 158.7 ± 56.1 | 39 | 180.6 ± 61.2 | 32 | 132.0 ± 34.3 |
Vitamin C | μg/mL | 5.5–16.8 | 66 | 3.5 ± 2.3 | 39 | 3.3 ± 2.6 | 27 | 3.7 ± 2.4 |
(Japanese Subjects | 44 | 11.4 ± 5.6 | 26 | 8.7 ± 6.2 | 18 | 14.1 ± 5.3) | ||
Vitamin E | mg/dL | 0.75–1.41 | 38 | 0.9 ± 0.3 | 20 | 0.8 ± 0.2 | 18 | 1.0 ± 0.3 |
MDA | U/L | Japanese Subjects | 66 | 109.5 ± 47.7 | 39 | 117.2 ± 49.3 | 27 | 98.4 ± 43.7 |
Total (n = 44) 62.5 ± 21.3 | ||||||||
Males (n = 26) 74.6 ± 25.5 | ||||||||
Females (n = 18) 51.8 ± 17.2 | ||||||||
Urine | ||||||||
8-OHdG | ng/mgCre | Japanese Subjects | 78 | 11.8 ± 3.4 | 47 | 11.3 ± 3.0 | 31 | 12.1 ± 5.7 |
Total (n = 32) 6.8 ± 4.4 | ||||||||
Males (n = 20) 7.5 ± 4.8 | ||||||||
Females (n = 12) 5.5 ± 4.3 |
ALT: alanine aminotransferase, MDA: malondialdehyde-modified LDL, BUN: blood urea nitrogen, Fe: iron, 8-OHdG: urinary 8-hydroxy-2'-deoxyguanosine Japanese References: the data of a commercial laboratory, the SRL Inc. (Tokyo, Japan). *** p < 0.001